ASCO 2016 Update: Immunotherapy and Melanoma

June 15, 2016

As one of the hottest topics in cancer research today, immunotherapy took center stage at the 2016 American Society of Clinical Oncology meeting in Chicago. Harold J. Burstein, MD, PhD, a breast oncologist in the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute, recently sat down with other oncologists to break down some of the meeting’s more important findings.

Below, he talks with Elizabeth I. Buchbinder, MD, a melanoma specialist, about some of the research related to pembrolizumab (Keytruda), which was used to treat former President Jimmy Carter, and other immunotherapy news.